dc.contributor.author |
MADHANAGOPAL, BHARATH RAJ |
en_US |
dc.contributor.author |
Zhang, Shunqing et al. |
en_US |
dc.date.accessioned |
2018-12-28T06:44:31Z |
|
dc.date.available |
2018-12-28T06:44:31Z |
|
dc.date.issued |
2018-12 |
en_US |
dc.identifier.citation |
Trends in Biochemical Sciences, 43(12) pp997-1013. |
en_US |
dc.identifier.issn |
0968-0004 |
en_US |
dc.identifier.issn |
1362-4326 |
en_US |
dc.identifier.uri |
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/1435 |
|
dc.identifier.uri |
https://doi.org/10.1016/j.tibs.2018.09.010 |
en_US |
dc.description.abstract |
DNA can be used as a building block for creating nanoscale structures.DNA nanostructures are programmable, offering unique characteristics for use as drug delivery carriers.DNA nanocarriers can be targeted to specific cells; be triggered using chemical, molecular or environment cues to release drugs; and offer tunable cellular uptake profiles.DNA nanocarriers are used for a variety of cargos including small molecules, therapeutic oligonucleotides, antibodies, peptides, and photosensitizers.Nanocarriers can be functionalized to provide a -see-and-treat- strategy for the creation of theranostics. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Elsevier B.V. |
en_US |
dc.subject |
DNA nanotechnology |
en_US |
dc.subject |
Drug delivery |
en_US |
dc.subject |
DNA origami |
en_US |
dc.subject |
Nanocarriers |
en_US |
dc.subject |
DNA nanocages |
en_US |
dc.subject |
DNA nanostructures |
en_US |
dc.subject |
TOC-DEC-2018 |
en_US |
dc.subject |
2018 |
en_US |
dc.title |
DNA Nanocarriers: Programmed to Deliver |
en_US |
dc.type |
Article |
en_US |
dc.contributor.department |
Dept. of Biology |
en_US |
dc.identifier.sourcetitle |
Trends in Biochemical Sciences |
en_US |
dc.publication.originofpublisher |
Foreign |
en_US |